Before starting a GLP-1 medication, a thorough baseline lab panel typically includes a comprehensive metabolic panel, a complete blood count, thyroid function testing, a lipid panel, and hemoglobin A1c, along with a review of your personal and family medical history — not just to confirm you're a safe candidate, but to establish a true starting point your provider can measure progress against as treatment continues.

Why lab work matters beyond just candidacy screening?

Baseline labs serve two purposes: identifying anything that would make GLP-1 treatment inappropriate or require extra caution, and establishing your true starting metabolic picture, which allows your provider to track meaningful changes, like improving blood sugar or cholesterol, as treatment progresses, rather than relying on weight alone as the only marker of success.

Typical components of a baseline panel

  • Comprehensive metabolic panel, assessing kidney and liver function, electrolytes, and blood sugar
  • Hemoglobin A1c, providing a picture of average blood sugar over the past several months
  • Complete blood count, screening for anemia or other blood-related concerns
  • Lipid panel, assessing cholesterol and triglycerides, both of which often improve alongside weight loss
  • Thyroid function testing, since thyroid disorders can affect weight and should be identified and addressed as part of a complete picture

Why personal and family history matters just as much?

Certain personal or family history factors are directly relevant to GLP-1 safety screening, particularly a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, both of which are contraindications to this medication class. A history of pancreatitis, significant gastrointestinal disease, or gallbladder issues is also relevant and worth discussing openly at your consultation.

What additional testing may be relevant?

Depending on your individual history and goals, your provider may also recommend additional testing, such as a body composition assessment to establish a baseline for tracking fat versus muscle changes over treatment, or additional hormone testing if there are other relevant symptoms or concerns to address alongside weight management.

What ongoing monitoring do you need after you start?

Baseline labs are just the starting point — most GLP-1 treatment plans include periodic follow-up labs during treatment to confirm your metabolic markers are moving in the right direction and to catch any concerns early, rather than a one-time check that's never revisited.

How do you start your journey with a complete picture?

A thorough baseline evaluation isn't a bureaucratic hurdle — it's what allows your provider to build a genuinely personalized, safely monitored treatment plan around your specific health picture. Our clinical team will walk you through exactly what testing is recommended for you at your consultation.

1. Data from the STEP clinical trial program found that patients who started semaglutide with prediabetes-range A1c levels returned to a normal A1c in 84–85% of cases after 68 weeks of treatment — a result that's only measurable, for you individually, if a baseline A1c was drawn before starting.
Specific lab requirements vary by individual health history and provider protocol. This article is educational and does not replace individualized medical guidance from your prescribing provider.